Literature DB >> 22094256

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.

Lars Anders1, Nan Ke, Per Hydbring, Yoon J Choi, Hans R Widlund, Joel M Chick, Huili Zhai, Marc Vidal, Stephen P Gygi, Pascal Braun, Piotr Sicinski.   

Abstract

Cyclin D-dependent kinases (CDK4 and CDK6) are positive regulators of cell cycle entry and they are overactive in the majority of human cancers. However, it is currently not completely understood by which cellular mechanisms CDK4/6 promote tumorigenesis, largely due to the limited number of identified substrates. Here we performed a systematic screen for substrates of cyclin D1-CDK4 and cyclin D3-CDK6. We identified the Forkhead Box M1 (FOXM1) transcription factor as a common critical phosphorylation target. CDK4/6 stabilize and activate FOXM1, thereby maintain expression of G1/S phase genes, suppress the levels of reactive oxygen species (ROS), and protect cancer cells from senescence. Melanoma cells, unlike melanocytes, are highly reliant on CDK4/6-mediated senescence suppression, which makes them particularly susceptible to CDK4/6 inhibition. 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094256      PMCID: PMC3237683          DOI: 10.1016/j.ccr.2011.10.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  37 in total

1.  Targets of the cyclin-dependent kinase Cdk1.

Authors:  Jeffrey A Ubersax; Erika L Woodbury; Phuong N Quang; Maria Paraz; Justin D Blethrow; Kavita Shah; Kevan M Shokat; David O Morgan
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

2.  Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs.

Authors:  John C Obenauer; Lewis C Cantley; Michael B Yaffe
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 3.  E2F target genes: unraveling the biology.

Authors:  Adrian P Bracken; Marco Ciro; Andrea Cocito; Kristian Helin
Journal:  Trends Biochem Sci       Date:  2004-08       Impact factor: 13.807

4.  The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration.

Authors:  Xinhe Wang; Hiroaki Kiyokawa; Margaret B Dennewitz; Robert H Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

5.  Proteome-scale purification of human proteins from bacteria.

Authors:  Pascal Braun; Yanhui Hu; Binghua Shen; Allison Halleck; Malvika Koundinya; Ed Harlow; Joshua LaBaer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

6.  Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.

Authors:  Xianghong Zou; Dipankar Ray; Aileen Aziyu; Konstantin Christov; Alexander D Boiko; Andrei V Gudkov; Hiroaki Kiyokawa
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

Review 7.  Cyclin D-dependent kinases, INK4 inhibitors and cancer.

Authors:  Sagrario Ortega; Marcos Malumbres; Mariano Barbacid
Journal:  Biochim Biophys Acta       Date:  2002-03-14

8.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

9.  FoxM1, a critical regulator of oxidative stress during oncogenesis.

Authors:  Hyun Jung Park; Janai R Carr; Zebin Wang; Veronique Nogueira; Nissim Hay; Angela L Tyner; Lester F Lau; Robert H Costa; Pradip Raychaudhuri
Journal:  EMBO J       Date:  2009-08-20       Impact factor: 11.598

10.  Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators.

Authors:  Michael L Major; Rita Lepe; Robert H Costa
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more
  238 in total

1.  Dividing and conquering: controlling advanced melanoma by targeting oncogene-defined subsets.

Authors:  Keith T Flaherty
Journal:  Clin Exp Metastasis       Date:  2012-06-03       Impact factor: 5.150

2.  Modification of the DNA damage response by therapeutic CDK4/6 inhibition.

Authors:  Jeffry L Dean; A Kathleen McClendon; Erik S Knudsen
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

Review 3.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

Review 4.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Yi Liu; Christopher McNair; Alex Haber; Maryna Perepelyuk; Anshul Bhardwaj; Sankar Addya; Adam Ertel; Sunday Shoyele; Ruth Birbe; Joseph M Salvino; Adam P Dicker; Karen E Knudsen; Robert B Den
Journal:  Clin Cancer Res       Date:  2018-01-08       Impact factor: 12.531

Review 6.  Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions.

Authors:  Smruthi Vijayaraghavan; Stacy Moulder; Khandan Keyomarsi; Rachel M Layman
Journal:  Target Oncol       Date:  2018-02       Impact factor: 4.493

7.  Chemoproteomic Profiling Uncovers CDK4-Mediated Phosphorylation of the Translational Suppressor 4E-BP1.

Authors:  Dylan C Mitchell; Arya Menon; Amanda L Garner
Journal:  Cell Chem Biol       Date:  2019-05-02       Impact factor: 8.116

8.  Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines.

Authors:  Margaret E McLaughlin-Drubin; Donglim Park; Karl Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

9.  Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Authors:  Julieann Rader; Mike R Russell; Lori S Hart; Michael S Nakazawa; Lili T Belcastro; Daniel Martinez; Yimei Li; Erica L Carpenter; Edward F Attiyeh; Sharon J Diskin; Sunkyu Kim; Sudha Parasuraman; Giordano Caponigro; Robert W Schnepp; Andrew C Wood; Bruce Pawel; Kristina A Cole; John M Maris
Journal:  Clin Cancer Res       Date:  2013-09-17       Impact factor: 12.531

Review 10.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.